Skip to content
AnalystLens

Willis Towers Watson Annual Report, Year Ended Dec 31, 2023

Filing Date
Filed February 22, 2024
Period End
December 31, 2023
Security
WTW
In the record · 2016–202610-K1210-Q338-K148

WTW filed 12 annual reports (10-K), 33 quarterly reports (10-Q) and 148 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Sep ’18Sep ’18
  2. Deal closed8-K · Oct ’20Oct ’20
  3. Leadership change8-K · Dec ’22Dec ’22
  4. Leadership change8-K · Nov ’26Nov ’26

Summary

Summary of the 10-K filed February 22, 2024. Cited figures are marked; the original filing is the authoritative source.

WTW (Willis Towers Watson Public Limited Company) reported revenue of $9.48 billiona for 2023, up from $8.87 billion in 2022, an increase of $617 million or 7% as reported and 8% organically.

Income from operations rose to $1.37 billionb from $1.18 billion, and net income attributable to WTW was $1.06 billion versus $1.01 billion. Diluted earnings per share from continuing operations were $9.95, compared with $9.34 in 2022. Adjusted EBITDA was $2.43 billion, with an adjusted EBITDA margin of 25.6%.

Results were driven by strong performances in both the Health, Wealth & Career and Risk & Broking segments, partially offset by higher salary and incentive costs and increased Transformation program spending of $386 millionc in transaction and transformation costs. Cash flow strengthened, with net cash from operating activities of $1.35 billion and free cash flow of $1.19 billion. The company repurchased $1.0 billion of shares in 2023, leaving about $1.3 billion of remaining authorization, and paid $352 million in dividends.

Total debt was $5.2 billiond at year-end, and the company reported interest expense of $235 million. Shareholders' equity declined to $9.52 billion, reflecting share repurchases and a $408 million pension-related other comprehensive loss. The filing also highlights ongoing risks: the Transformation program, now expected to generate annual cost savings above $425 million by the end of 2024, carries a total investment of $1.125 billion.

The company faces exposure to inflation, geopolitical conflicts, regulatory changes affecting its Medicare and health insurance businesses, and litigation related to errors and omissions claims. Management concluded that internal control over financial reporting was effective as of December 31, 2023.

Key Highlights

  1. Revenue rose 7% as reported to $9.48 billion, and organic revenue grew 8%, driven by both the HWC and R&B segments.
  2. Income from operations increased to $1.37 billion from $1.18 billion, with operating margin at 14.4% versus 13.3% in 2022.
  3. Adjusted EBITDA was $2.43 billion (25.6% margin) versus $2.39 billion in 2022; adjusted diluted EPS was $14.49 versus $13.41.
  4. Operating cash flow reached $1.35 billion and free cash flow was $1.19 billion (12.6% margin), up from $674 million in 2022.
  5. Share repurchases of $1.0 billion and dividends of $352 million were returned to shareholders in 2023; about $1.3 billion of repurchase authority remained at year-end.
  6. Transformation program now targets annual cost savings above $425 million by end-2024 on a total investment of $1.125 billion; $337 million of cumulative run-rate savings identified to date.
  7. Willis Re was sold to Arthur J. Gallagher & Co. in 2021, with a $750 million earnout payable in 2025 if triggers are met; transitional arrangements continue.

Financial Statements

FY2023 against FY2022

Line itemFY2023FY2022Change
Revenue$9.48B$8.87B+7.0%
Operating Expenses$8.12B$7.69B+5.6%
Operating Income$1.36B$1.18B+15.9%
Interest Expense$235.00M$208.00M+13.0%
Net Income$1.05B$1.01B+4.6%
EPS (Basic)$10.01$9.00+11.2%
EPS (Diluted)$9.95$8.98+10.8%
Shares Outstanding (Basic)105.00M112.00M−6.2%
Shares Outstanding (Diluted)106.00M112.00M−5.4%

Frequently Asked Questions

  1. How did WTW perform financially in 2023?

    Revenue grew 7% as reported to $9.48 billion, with organic growth of 8%. Income from operations rose to $1.37 billion and net income attributable to WTW reached $1.06 billion. Diluted EPS from continuing operations was $9.95, up from $9.34 in 2022.

  2. What are the main drivers of WTW's revenue growth?

    The filing attributes growth to strong performances in both segments and to higher interest income not allocated to the segments. Within HWC, Benefits Delivery & Outsourcing led organic growth, driven by Medicare Advantage and life policy volumes and increased outsourcing project activity. R&B grew organically by 10%, supported by strong new business and improved client retention in Corporate Risk & Broking.

  3. How much debt does WTW carry, and how is it managed?

    Total debt was $5.2 billion at December 31, 2023, including $650 million of 3.600% senior notes due in 2024. WTW issued $750 million of 5.350% senior notes due 2033 and used proceeds to repay $250 million of 4.625% notes. The company has a $1.5 billion revolving credit facility with no balance drawn, and was in compliance with all financial covenants.

  4. What is the status of the Transformation program?

    The three-year program, launched in Q4 2021, now expects annual cost savings above $425 million by end-2024. Cumulative costs are approximately $995 million plus about $130 million of capital expenditures. Restructuring charges were $68 million in 2023, and other transformation costs within transaction and transformation, net were $347 million.

  5. What are the key risks highlighted in the filing?

    Key risks include macroeconomic pressures such as inflation and interest rates, geopolitical conflicts including the Russia-Ukraine and Israel-Hamas wars, and regulatory changes affecting U.S. health insurance and Medicare marketing. The filing also flags errors and omissions litigation, cybersecurity threats, dependence on insurance carrier relationships, pension liabilities, and the execution risk of the Transformation program.